Company / Total Assets
Aurinia Pharmaceuticals Inc. Total Assets History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$751.6M
FY2025
5-year range
$470.9M / $751.6M
FY2021-FY2025
Trend
+36.5%
vs FY2024
Sector context
#102 of 214
Health Care
What the data says
At $752M, Aurinia Pharmaceuticals Inc.'s total assets ranks #102 of 214 in the Health Care sector. Total Assets has increased for 3 consecutive years, from $471M in FY2022 to $752M in FY2025.
Based on SEC 10-K filings.
$752M in FY2025 with a 5-year CAGR of +10.1%.
Improved from $548M to $752M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +16.9%
- 5-Year CAGR
- +10.1%
- 10-Year CAGR
- -
Sector benchmark
#102 of 214 in Health CareTop 48% of 214This company $751.6M Sector average $7.5B
▼
-89.9% below sector average
Key checks
Key Insights
- Aurinia Pharmaceuticals Inc.'s total assets has grown for 3 consecutive years.
- 5-year CAGR of +10.1%, indicating consistent growth.
- In FY2025, total assets increased 36.5% year-over-year.
- Ranks #102 out of 214 companies in the Health Care sector.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $751.6M | +36.5% |
| FY2024 | $550.6M | +0.5% |
| FY2023 | $548.1M | +16.4% |
| FY2022 | $470.9M | -13.3% |
| FY2021 | $543.4M | +17.2% |
| FY2020 | $463.7M | +43.0% |
| FY2019 | $324.3M | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026